Results 11 to 20 of about 2,173,558 (351)

Subcutaneous Injections of Nanofat Adipose-derived Stem Cell Grafting in Facial Rejuvenation

Plastic and Reconstructive Surgery, Global Open, 2020
Background: We aimed to assess whether our novel Nanofat grafting procedure improves skin quality while yielding a regenerative effect and whether this novel technique can also achieve a lifting effect.
S. Menkes, M. Luca, G. Soldati, L. Polla
semanticscholar   +1 more source

Effect of a reused insulin needle remaining in a patient's body

Journal of Diabetes Investigation, 2023
Diabetes is one of the most common chronic diseases at present, and insulin pen injection therapy plays an important role in the treatment of diabetes.
Yong‐jie Qiao, Yu Xin‐yuan, Rui‐ling Xu, Xiao‐yang Song, Shuo Ye, Ping Zhen, Sheng‐hu Zhou, Hao‐qiang Zhang   +7 more
doaj   +1 more source

Insulin‐derived amyloidosis without a palpable mass at the insulin injection site: A report of two cases

Journal of Diabetes Investigation, 2020
To date, almost all case reports of insulin‐derived amyloidosis described the presence of a subcutaneous mass that was observable on physical examination.
Terumasa Nagase, Keiichi Iwaya, Koichiro Kogure, Tamotsu Zako, Yohei Misumi, Minoru Kikuchi, Koichi Matsumoto, Masayuki Noritake, Yasuhiro Kawachi, Masaki Kobayashi, Yukio Ando, Yoshiya Katsura   +11 more
doaj   +1 more source

Real-World Analysis of Therapeutic Outcome in Type 1 Diabetes Mellitus at a Tertiary Care Center [PDF]

Diabetes & Metabolism Journal, 2022
Insulin replacement in type 1 diabetes mellitus (T1DM) needs intensified treatment, which can either be performed by multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII).
Antonia Kietaibl, Michaela Riedl, Latife Bozkurt   +2 more
doaj   +1 more source

Subcutaneous injection-induced cellulites [PDF]

BioMedicine, 2017
In the hospice ward where patients are in the terminal stages of cancer, it is common practice to give them a subcutaneous injection of pain relievers to reduce their pain and make them more comfortable. Most of these patients are elderly and have low blood pressure or poor veins, which often makes it difficult to inject them because of the ...
Cheng Kao-Chi, Huang Po-Tsung, Liu Chiu-Shong, Lin Wen-Yuan   +3 more
openaire   +3 more sources

Heterogeneous trajectory of depressive symptoms after repeated subcutaneous esketamine injections

Journal of Affective Disorders Reports, 2021
Background: Ketamine is an effective antidepressant with a 65–70% response rate and a fast onset of action. Esketamine (S-ketamine) has been found to be twice as potent as R-ketamine, while inducing fewer adverse effects, such as sedation and cognitive ...
Matheus Ghossain Barbosa, Luciana Maria Sarin, Marco Aurélio Tuena, Lorena Catarina Del Sant, Carolina Nakahira, Eduardo Jorge Muniz Magalhães, Victor Augusto Rodovalho Fava, Rodrigo Simonini Delfino, Matheus Souza Steglich, Camila Puertas, Ana Cecília Lucchese, Juliana Canada Surjan, Guilherme Lozi Abdo, Hugo Cogo-Moreira, José Alberto Del Porto, Acioly Luiz Tavares de Lacerda, Andrea Parolin Jackowski   +16 more
doaj   +1 more source

Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients [PDF]

, 2005
Introduction: Facial lipoatrophy is a crucial problem of HIV-infected patients undergoing highly active antiretroviral therapy (HAART). Poly-L-lactic acid (PLA), provided as New-Fill(R)/Sculptra(TM), is known as one possible treatment option. In 2004 PLA
Anonymous, Boix V, Borelli C, Bornhovd E, Buffet M, Carr A, Carr A, Carr A, Cofrancesco, Eppley BL, Grinspoon S, Group EPL, Hansen BR, James J, Mallon PW, Martinez E, McComsey G, Moyle G, Moyle GJ, Nolan D, Oppel T, Perry CM, Schurig V, Valantin MA, Villarroya F, Woerle B   +25 more
core   +1 more source

Improving the clinical value and utility of CGM systems: issues and recommendations : a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group [PDF]

, 2017
The first systems for continuous glucose monitoring (CGM) became available over 15 years ago. Many then believed CGM would revolutionise the use of intensive insulin therapy in diabetes; however, progress towards that vision has been gradual.
Bergenstal, Richard M., Fleming, G. Alexander, Heinemann, Lutz, Holl, Reinhard W., Peters, Anne L., Petrie, John R.   +5 more
core   +4 more sources

Evaluating the effects of permanent subcutaneous insulin infusion versus multiple daily insulin injections on glycated hemoglobin (HbA1C) levels in patients with type 2 diabetes: a systematic review and meta-analysis based on clinical trials [PDF]

مجله پزشکی دانشگاه علوم پزشکی تبریز
Background. Diabetes is one of the most common chronic and metabolic diseases. This systematic review and meta-analysis study aimed to compare the effects of multiple daily insulin injections against permanent subcutaneous insulin injections on glycated ...
Abdollah Mohammadian Hafshejani, Soleiman Kheiri, Zahra Karimi   +2 more
doaj   +1 more source

Clinical Trials of Immunogene Therapy for Spontaneous Tumors in Companion Animals [PDF]

, 2014
Despite the important progress obtained in the treatment of some pets’ malignancies, new treatments need to be developed. Being critical in cancer control and progression, the immune system’s appropriate modulation may provide effective therapeutic ...
Finocchiaro, Liliana Maria Elena, Glikin, Gerardo Claudio   +1 more
core   +4 more sources